奥马珠单抗治疗儿童慢性自发性和物理性荨麻疹患者：病例系列 - Suppr

Suppr

超能文献

Management of pediatric chronic spontaneous and physical urticaria patients with omalizumab: case series.

作者信息

Netchiporouk Elena, Nguyen Christopher H, Thuraisingham Thusanth, Jafarian Fatemeh, Maurer Marcus, Ben-Shoshan Moshe

机构信息

Division of Dermatology, McGill University Health Centre, Montreal, QC, Canada.

Department of Dermatology and Allergy, Charité Universitätsmedizin, Berlin, Germany.

出版信息

Pediatr Allergy Immunol. 2015 Sep;26(6):585-8. doi: 10.1111/pai.12407. Epub 2015 Jun 14.

DOI:10.1111/pai.12407

PMID:26012951

Abstract

摘要

相似文献

Management of pediatric chronic spontaneous and physical urticaria patients with omalizumab: case series.

Pediatr Allergy Immunol. 2015 Sep;26(6):585-8. doi: 10.1111/pai.12407. Epub 2015 Jun 14.

Successful omalizumab treatment of severe solar urticaria in a 6-year-old child.

Pediatr Allergy Immunol. 2015 Sep;26(6):588-90. doi: 10.1111/pai.12441.

Treatment with omalizumab in a 16-year-old Caucasian girl with refractory solar urticaria.

Pediatr Allergy Immunol. 2015 Sep;26(6):583-5. doi: 10.1111/pai.12413. Epub 2015 Jul 1.

Bullous Delayed Pressure Urticaria Responding to Omalizumab.

Acta Derm Venereol. 2016 Mar;96(3):416-7. doi: 10.2340/00015555-2224.

Efficacy and rapid activity of omalizumab retreatment in chronic spontaneous urticaria.

J Am Acad Dermatol. 2018 Jun;78(6):1211-1213. doi: 10.1016/j.jaad.2017.11.047. Epub 2017 Dec 5.

Efficacy of omalizumab in severe chronic spontaneous urticaria: Real life data from a Greek tertiary center.

Dermatol Ther. 2018 Nov;31(6):e12739. doi: 10.1111/dth.12739. Epub 2018 Nov 5.

Omalizumab in the Treatment of Chronic Inducible Urticaria.

Actas Dermosifiliogr. 2017 Jun;108(5):423-431. doi: 10.1016/j.ad.2016.07.018. Epub 2016 Oct 5.

Efficacy of omalizumab 150 mg/month as a maintenance dose in patients with severe chronic spontaneous urticaria showing a prompt and complete response to the drug.

Allergy. 2018 Nov;73(11):2242-2244. doi: 10.1111/all.13549. Epub 2018 Aug 8.

Efficacy of Omalizumab Treatment with Concomitant Antihistamines as Needed for Moderate, Refractory Chronic Spontaneous Urticaria.

Acta Derm Venereol. 2018 Apr 16;98(4):446-448. doi: 10.2340/00015555-2886.

Timing and duration of omalizumab response in patients with chronic idiopathic/spontaneous urticaria.

J Allergy Clin Immunol. 2016 Feb;137(2):474-81. doi: 10.1016/j.jaci.2015.08.023. Epub 2015 Oct 21.

引用本文的文献

Case of benralizumab-induced exacerbations of chronic spontaneous urticaria.

Clin Case Rep. 2022 Jun 19;10(6):e05930. doi: 10.1002/ccr3.5930. eCollection 2022 Jun.

An Overview of Off-Label Use of Humanized Monoclonal Antibodies in Paediatrics.

Medicina (Kaunas). 2022 Apr 29;58(5):625. doi: 10.3390/medicina58050625.

Biologic drugs in chronic spontaneous urticaria.

Acta Biomed. 2021 Nov 29;92(S7):e2021527. doi: 10.23750/abm.v92iS7.12415.

[Not Available].

Allergo J. 2021;30(2):40-55. doi: 10.1007/s15007-021-4772-2. Epub 2021 Mar 26.

Management of Pediatric Chronic Spontaneous Urticaria: A Review of Current Evidence and Guidelines.

J Asthma Allergy. 2021 Mar 9;14:187-199. doi: 10.2147/JAA.S249765. eCollection 2021.

Anti-IgE for the Treatment of Chronic Urticaria.

Immunotargets Ther. 2021 Feb 17;10:27-45. doi: 10.2147/ITT.S261416. eCollection 2021.

Safety and effectiveness of omalizumab for the treatment of chronic urticaria in pediatric patients.

Pediatr Allergy Immunol. 2021 May;32(4):720-726. doi: 10.1111/pai.13426. Epub 2021 Jan 18.

Urticaria: recommendations from the Italian Society of Allergology, Asthma and Clinical Immunology and the Italian Society of Allergological, Occupational and Environmental Dermatology.

Clin Mol Allergy. 2020 May 6;18:8. doi: 10.1186/s12948-020-00123-8. eCollection 2020.

Management of chronic urticaria in children: a clinical guideline.

Ital J Pediatr. 2019 Aug 15;45(1):101. doi: 10.1186/s13052-019-0695-x.

Chronic Urticaria: An Overview of Treatment and Recent Patents.

Recent Pat Inflamm Allergy Drug Discov. 2019;13(1):27-37. doi: 10.2174/1872213X13666190328164931.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Management of pediatric chronic spontaneous and physical urticaria patients with omalizumab: case series.

Pediatr Allergy Immunol. 2015 Sep;26(6):585-8. doi: 10.1111/pai.12407. Epub 2015 Jun 14.

Successful omalizumab treatment of severe solar urticaria in a 6-year-old child.

Pediatr Allergy Immunol. 2015 Sep;26(6):588-90. doi: 10.1111/pai.12441.

Treatment with omalizumab in a 16-year-old Caucasian girl with refractory solar urticaria.

Pediatr Allergy Immunol. 2015 Sep;26(6):583-5. doi: 10.1111/pai.12413. Epub 2015 Jul 1.

Bullous Delayed Pressure Urticaria Responding to Omalizumab.

Acta Derm Venereol. 2016 Mar;96(3):416-7. doi: 10.2340/00015555-2224.

Efficacy and rapid activity of omalizumab retreatment in chronic spontaneous urticaria.

J Am Acad Dermatol. 2018 Jun;78(6):1211-1213. doi: 10.1016/j.jaad.2017.11.047. Epub 2017 Dec 5.

Efficacy of omalizumab in severe chronic spontaneous urticaria: Real life data from a Greek tertiary center.

Dermatol Ther. 2018 Nov;31(6):e12739. doi: 10.1111/dth.12739. Epub 2018 Nov 5.

Omalizumab in the Treatment of Chronic Inducible Urticaria.

Actas Dermosifiliogr. 2017 Jun;108(5):423-431. doi: 10.1016/j.ad.2016.07.018. Epub 2016 Oct 5.

Efficacy of omalizumab 150 mg/month as a maintenance dose in patients with severe chronic spontaneous urticaria showing a prompt and complete response to the drug.

Allergy. 2018 Nov;73(11):2242-2244. doi: 10.1111/all.13549. Epub 2018 Aug 8.

Efficacy of Omalizumab Treatment with Concomitant Antihistamines as Needed for Moderate, Refractory Chronic Spontaneous Urticaria.

Acta Derm Venereol. 2018 Apr 16;98(4):446-448. doi: 10.2340/00015555-2886.

Timing and duration of omalizumab response in patients with chronic idiopathic/spontaneous urticaria.

J Allergy Clin Immunol. 2016 Feb;137(2):474-81. doi: 10.1016/j.jaci.2015.08.023. Epub 2015 Oct 21.

引用本文的文献

Case of benralizumab-induced exacerbations of chronic spontaneous urticaria.

Clin Case Rep. 2022 Jun 19;10(6):e05930. doi: 10.1002/ccr3.5930. eCollection 2022 Jun.

An Overview of Off-Label Use of Humanized Monoclonal Antibodies in Paediatrics.

Medicina (Kaunas). 2022 Apr 29;58(5):625. doi: 10.3390/medicina58050625.

Biologic drugs in chronic spontaneous urticaria.

Acta Biomed. 2021 Nov 29;92(S7):e2021527. doi: 10.23750/abm.v92iS7.12415.

[Not Available].

Allergo J. 2021;30(2):40-55. doi: 10.1007/s15007-021-4772-2. Epub 2021 Mar 26.

Management of Pediatric Chronic Spontaneous Urticaria: A Review of Current Evidence and Guidelines.

J Asthma Allergy. 2021 Mar 9;14:187-199. doi: 10.2147/JAA.S249765. eCollection 2021.

Anti-IgE for the Treatment of Chronic Urticaria.

Immunotargets Ther. 2021 Feb 17;10:27-45. doi: 10.2147/ITT.S261416. eCollection 2021.

Safety and effectiveness of omalizumab for the treatment of chronic urticaria in pediatric patients.

Pediatr Allergy Immunol. 2021 May;32(4):720-726. doi: 10.1111/pai.13426. Epub 2021 Jan 18.

Urticaria: recommendations from the Italian Society of Allergology, Asthma and Clinical Immunology and the Italian Society of Allergological, Occupational and Environmental Dermatology.

Clin Mol Allergy. 2020 May 6;18:8. doi: 10.1186/s12948-020-00123-8. eCollection 2020.

Management of chronic urticaria in children: a clinical guideline.

Ital J Pediatr. 2019 Aug 15;45(1):101. doi: 10.1186/s13052-019-0695-x.

Chronic Urticaria: An Overview of Treatment and Recent Patents.

Recent Pat Inflamm Allergy Drug Discov. 2019;13(1):27-37. doi: 10.2174/1872213X13666190328164931.